Cargando…
Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
Objective: The aim of this study was to explore the respective use of angiotensin-converting-enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) on the outcomes of patients who could be weaned from dialysis-requiring acute kidney injury (AKI-D). Methods: This case–control study enrolle...
Autores principales: | Wu, Vin-Cent, Lin, Yu-Feng, Teng, Nai-Chi, Yang, Shao-Yu, Chou, Nai-Kuan, Tsao, Chun-Hao, Chen, Yung-Ming, Chueh, Jeff S, Chen, Likwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065477/ https://www.ncbi.nlm.nih.gov/pubmed/35517809 http://dx.doi.org/10.3389/fphar.2022.714658 |
Ejemplares similares
-
Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021) -
The Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on Clinical Outcomes of Acute Kidney Disease Patients: A Systematic Review and Meta-Analysis
por: Chen, Jui-Yi, et al.
Publicado: (2021) -
Unsupervised clustering identifies sub-phenotypes and reveals novel outcome predictors in patients with dialysis-requiring sepsis-associated acute kidney injury
por: Lai, Chun-Fu, et al.
Publicado: (2023) -
The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
por: Zhu, Xu, et al.
Publicado: (2022) -
Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
por: Zhao, Mingming, et al.
Publicado: (2021)